Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma

CANCER CELL

CELL PRESS

1. Corona Fund of the Goethe University Frankfurt
2. German Research Foundation DFG [SFB/CRC/IRTG 1292]
3. Hessen State Ministry for Higher Education, Research, and the Arts (Sondervermgen Hessisches Ministerium fur Wissenschaft und Kunst) [III L 5-519/03/03.001-[0015]]